Report: Drugs for dual eligibles cost more under Medicare Part D

Share this article:
Report: Drugs for dual eligibles cost more under Medicare Part D
Report: Drugs for dual eligibles cost more under Medicare Part D
Prescription drugs for Medicare and Medicaid-eligible beneficiaries cost 30% more under Medicare Part D than they would if Medicaid paid the bill, according to a new report from the House Committee on Oversight and Government Reform.

The report, which was released Thursday, also found that drug manufacturers received "windfall" revenue of more than $3.7 billion during the first two years of Part D. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 required that Medicare Part D, not Medicaid, cover the cost of drugs for dual eligibles. Many nursing-home residents fall into this "dual-eligible" category.

Democrats in the House say this overpayment is an unjustified burden on the taxpayer, and they seek to correct the problem through new legislation. But House Republicans have countered that the new report overlooks important aspects and benefits to dual eligibles contained in the Part D program. Under Part D, for example, dual eligibles have access to a greater variety of prescription drugs.
Share this article:

More in News

Also in the news for Sept. 22, 2014

ER support program can reduce hospital admissions among seniors, study says ... Researchers find defect that may lead to Alzheimer's ... Technical glitch may cause milions in payment delays for physicians who adopted EHRs

Enterovirus hits KY nursing home

Nine residents at the Heritage Hall nursing home are confirmed to have a strain of enterovirus, according to local reports.

AHCA applauds Senate passage of IMPACT Act

The Senate approved the Improving Medicare Post-Acute Care Transformation Act, drawing praise from the American Health Care Association and the National Association for the Support of Long Term Care.